Glomerular filtration rate early after liver transplantation independently predicts atherosclerotic events

Ramzi Hassouneh, Samarth Patel, Steve Shen, Anh Bui, Taseen Syed, Sean Flynn, Vaishali Patel, Mark D. Muthiah, Amit Sharma, Chandra Bhati, Mohammad Shadab Siddiqui – 5 February 2022 – Cardiovascular disease (CVD) is an important cause of mortality among liver transplantation (LT) recipients; however, the data on CVD risk stratification following LT are limited. Thus, the primary aim of this study was to evaluate the association between decline in renal function early after LT and atherosclerotic events. This retrospective study included all patients receiving LT between 2007 and 2019.

Core implementation strategies for improving cirrhosis care in the Veterans Health Administration

Vera Yakovchenko, Timothy R. Morgan, Edward J. Miech, Brittney Neely, Carolyn Lamorte, Sandra Gibson, Lauren A. Beste, Heather McCurdy, Dawn Scott, Rachel I. Gonzalez, Angela M. Park, Byron J. Powell, Jasmohan S. Bajaj, Jason A. Dominitz, Maggie Chartier, David B. Ross, Matthew J. Chinman, Shari S. Rogal – 5 February 2022

Prevalence and Risk Factors of Advanced Liver Fibrosis in a Population‐Based Study in Germany

Yvonne Huber, Andreas Schulz, Irene Schmidtmann, Manfred Beutel, Norbert Pfeiffer, Thomas Münzel, Peter R. Galle, Philipp S. Wild, Karl J. Lackner, Jörn M. Schattenberg – 4 February 2022 – The prevalence of liver disease, and especially of advanced liver fibrosis, in the German population is poorly defined. The aim of the study was to explore liver enzymes and surrogate scores of hepatic steatosis and advanced hepatic fibrosis in a population‐based cohort study in Germany.

Subscribe to